BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24458845)

  • 21. Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada.
    Hartley T; Cavallone L; Sabbaghian N; Silva-Smith R; Hamel N; Aleynikova O; Smith E; Hastings V; Pinto P; Tischkowitz M; Tomiak E; Foulkes WD
    Hered Cancer Clin Pract; 2014; 12(1):19. PubMed ID: 25225577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset colorectal cancer: a sporadic or inherited disease?
    Stigliano V; Sanchez-Mete L; Martayan A; Anti M
    World J Gastroenterol; 2014 Sep; 20(35):12420-30. PubMed ID: 25253942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers.
    Portnoy DB; Loud JT; Han PK; Mai PL; Greene MH
    Health Psychol; 2015 Jul; 34(7):709-17. PubMed ID: 25243716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
    Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
    Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.
    Geurts-Giele WR; Leenen CH; Dubbink HJ; Meijssen IC; Post E; Sleddens HF; Kuipers EJ; Goverde A; van den Ouweland AM; van Lier MG; Steyerberg EW; van Leerdam ME; Wagner A; Dinjens WN
    J Pathol; 2014 Dec; 234(4):548-59. PubMed ID: 25111426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.
    Pruss D; Morris B; Hughes E; Eggington JM; Esterling L; Robinson BS; van Kan A; Fernandes PH; Roa BB; Gutin A; Wenstrup RJ; Bowles KR
    Breast Cancer Res Treat; 2014 Aug; 147(1):119-32. PubMed ID: 25085752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
    Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
    J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal contraceptive use and breast cancer in Thai women.
    Poosari A; Promthet S; Kamsa-ard S; Suwanrungruang K; Longkul J; Wiangnon S
    J Epidemiol; 2014; 24(3):216-20. PubMed ID: 24614914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.
    Huber D; Seitz S; Kast K; Emons G; Ortmann O
    Arch Gynecol Obstet; 2020 Apr; 301(4):875-884. PubMed ID: 32140806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.
    Schrijver LH; Olsson H; Phillips KA; Terry MB; Goldgar DE; Kast K; Engel C; Mooij TM; Adlard J; Barrowdale D; Davidson R; Eeles R; Ellis S; Evans DG; Frost D; Izatt L; Porteous ME; Side LE; Walker L; Berthet P; Bonadona V; Leroux D; Mouret-Fourme E; Venat-Bouvet L; Buys SS; Southey MC; John EM; Chung WK; Daly MB; Bane A; van Asperen CJ; Gómez Garcia EB; Mourits MJE; van Os TAM; Roos-Blom MJ; Friedlander ML; McLachlan SA; Singer CF; Tan YY; Foretova L; Navratilova M; Gerdes AM; Caldes T; Simard J; Olah E; Jakubowska A; Arver B; Osorio A; Noguès C; Andrieu N; Easton DF; van Leeuwen FE; Hopper JL; Milne RL; Antoniou AC; Rookus MA;
    JNCI Cancer Spectr; 2018 Apr; 2(2):pky023. PubMed ID: 31360853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
    Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptive and breast cancer: do benefits outweigh the risks? A case - control study from Jordan.
    Bardaweel SK; Akour AA; Al-Muhaissen S; AlSalamat HA; Ammar K
    BMC Womens Health; 2019 Jun; 19(1):72. PubMed ID: 31159800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies.
    Park J; Huang D; Chang YJ; Lim MC; Myung SK
    Carcinogenesis; 2022 Apr; 43(3):231-242. PubMed ID: 34958358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer.
    Metcalfe KA; Lubinski J; Gronwald J; Huzarski T; McCuaig J; Lynch HT; Karlan B; Foulkes WD; Singer CF; Neuhausen SL; Senter L; Eisen A; Sun P; Narod SA;
    Clin Genet; 2018 May; 93(5):1063-1068. PubMed ID: 29206279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of new models for primary dysmenorrhea treatment: low-power visible-light-activated photodynamic therapy and oral contraceptives.
    Wang Y; Chen J; Zhang Z; Ding X; Gan J; Guo Y; Liang W; Wang Y; Deng Y; Sun A
    Front Med (Lausanne); 2024; 11():1388045. PubMed ID: 38751981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifiable risk factors in women at high risk of breast cancer: a systematic review.
    Cohen SY; Stoll CR; Anandarajah A; Doering M; Colditz GA
    Breast Cancer Res; 2023 Apr; 25(1):45. PubMed ID: 37095519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.
    van Bommel MHD; IntHout J; Veldmate G; Kets CM; de Hullu JA; van Altena AM; Harmsen MG
    Hum Reprod Update; 2023 Mar; 29(2):197-217. PubMed ID: 36383189
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.